Revere Partners

What Revere Partners does

Revere Partners is a New York-based venture capital firm founded in 2019 by Dr. Jeremy Krell and David Arena, operating as the first independent VC fund exclusively dedicated to oral health. The firm invests across Seed to Series B stages in dental startups spanning software, fintech, biotech, medtech, specialty products, and clinical services, with 40+ portfolio companies and claimed diligence on over 1,000 dental startups through a proprietary pipeline database. Beyond the core VC fund, Revere operates three additional business lines: Corporate Services (curated deal flow, market intelligence, and M&A support for industry corporates), Revere+ (an SPV platform enabling accredited investors to back single companies), and Revere+ for Pros (modular fund administration, compliance, IR, and portfolio success services for external fund managers). The firm also operates RISE Health as an inclusion-driven oral health subsidiary fund, and is currently raising Fund III with a stated $200M AUM target.

The firm's value proposition rests on domain specialization supported by a network of senior strategic advisors drawn from the ADA, Delta Dental, Colgate, Henry Schein, and leading dental schools. Revenue is generated through traditional VC management fees (2–3% of AUM), performance-based carried interest, corporate services fees, and platform fees from Revere+ and Revere+ for Pros. Operating geographies span North America, Europe, Asia, and South America, with deal flow sourced through DSOs, manufacturers, insurers, distributors, labs, professional associations, and a startup application portal. The competitive positioning emphasizes category-of-one status in oral health venture investing, with distribution reach claimed across over 100,000 dental practices worldwide through ecosystem connections.

Name

Revere Partners

Legal name

Revere Partners

Website

https://reverepartnersvc.com

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

11–50 employees

Short description

Revere Partners is a New York-based venture capital firm that invests exclusively in early-stage oral health startups (Seed to Series B), while also offering corporate deal-flow services, an SPV syndication platform (Revere+), and modular fund administration (Revere+ for Pros).

Ownership category

akta.pro rank

Product category

Venture Capital Management

NAICS

Open-End Investment Funds (525910)

SIC

Services-Management Consulting Services (8742)

akta.pro primary industry

Joint Venture CVC / Consortium Funds (Multi-corporate) (FSANAHAE)

Keywords

• Venture capital management
• Oral health investments
• Fund administration services
• Special purpose vehicles
• Dental startup funding

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Venture Capital Management Fees: Traditional VC fund management fees (2-3% of AUM) charged to limited partners for fund administration and investment management services
2. Carried Interest (Carry): Performance-based carried interest on successful portfolio company exits, typically 20% of profits above the hurdle rate
3. Corporate Services Fees: Customized deal flow, market intelligence, commercial partnerships, investment and M&A support services for corporate partners
4. Revere+ SPV Platform: Platform fees from single-company SPVs allowing startups to raise capital directly from accredited investors
5. Revere+ for Pros Fund Admin: Fund administration services including fund formation, compliance, reporting, portal management for fund managers across verticals

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels7 records

Core offering

Revere Partners is a venture capital firm that invests in early-stage oral health companies from seed through Series B. Beyond fund management, the firm offers three adjacent services: a Corporate Services program that connects portfolio companies with strategic partners across the oral health ecosystem, a Revere+ SPV platform that enables accredited investors to co-invest alongside the fund through special purpose vehicles, and Revere+ for Pros, a white-label fund administration offering provided to other venture firms.

Product overview

Revere Partners is a venture capital firm offering a suite of investment and fund administration services for the oral health industry. The core offering includes a Venture Capital Fund (Seed to Series B investments in oral health technology), Corporate Services (deal flow and market intelligence for partners), Revere+ (SPV platform for single-company capital raises), and Revere+ for Pros (fund administration and investment services). These services are designed to support founders, corporate partners, and investors throughout the oral health investment lifecycle.

Differentiator

Problem solved

Functional benefit

Brands

• Revere+: Platform for single companies to raise capital directly from accredited investors through special purpose vehicles (SPVs)
• Revere+ for Pros (RFP)

Products and services

• Revere Partners Venture Fund Core venture capital fund that invests equity capital in early-stage oral health startups spanning seed through Series B stages, for founders building in dentistry and adjacent oral health categories.
• Revere Corporate Services Program offering oral health startups access to strategic corporate partnerships, distribution channels, and enterprise relationships, designed for portfolio companies seeking commercial traction beyond capital.
• Revere+ SPV Platform Platform that allows accredited investors and family offices to co-invest in Revere Partners portfolio companies through special purpose vehicles, providing access to category-specialized deal flow.
• Revere+ for Pros White-label fund administration service for other venture and private equity fund managers, providing back-office operations support on a subscription basis.

Named customers10 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Four partnerships are on record, tiered event partner and partnership.

• Dental VIP Summitevent partnerGTM or Marketing Partner · 28 January 2024Jeremy Krell serves as co-chair of Dental VIP Summit addressing dental-medical integration, DSO evolution, and capital formation in oral health
• ToothappspartnershipStrategic or Co-development Partner · 12 January 2023Partnership announced January 2023 to facilitate dental innovation through connected platforms
• Seattle Study ClubpartnershipStrategic or Co-development Partner · 29 November 2022Partnership announced November 2022 to advance dental education and clinical excellence
• Workman School of Dental MedicinepartnershipStrategic or Co-development Partner · 29 November 2022Partnership with dental school to support education and innovation in oral health

Scale indicators7 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Flare Capital Partners: Flare Capital is a healthcare-focused venture capital firm investing in early-stage and growth-stage health technology companies, often at Seed to Series B. It is comparable to Revere as a sector-specialized healthcare VC with a similar stage focus, fund structure, and emphasis on industry-specific networks and thesis-driven investing.
• CareCapital: CareCapital is a dental-focused venture capital and growth equity firm, primarily active in Asia, that invests across the oral health value chain. It is the most direct comparable to Revere Partners given its exclusive dental vertical focus, multi-stage investment approach, and similar fund structure targeting oral health startups and growth-stage companies.

Broad incumbents

• Andreessen Horowitz (a16z Bio): Andreessen Horowitz is one of the largest and most active venture capital firms, with a dedicated bio/healthcare fund (a16z Bio) investing across healthcare, biotech, and digital health. It is a broad incumbent that competes for healthcare Seed-to-Series B opportunities overlapping with Revere's investment stages, though with a far broader sector mandate and much larger fund sizes.
• Vivo Capital: Vivo Capital is a healthcare-focused investment firm investing across venture, growth, and buyout stages in biotech, medtech, and healthcare services. It is a broad incumbent with a healthcare-only mandate that overlaps with Revere's medical-device and digital health oral health investments, though at typically larger check sizes and later stages.
• Welsh, Carson, Anderson & Stowe: Welsh, Carson, Anderson & Stowe is a private equity firm with a dedicated healthcare focus, investing across healthcare services, medical devices, and healthcare technology. It is a broad incumbent comparable to Revere's healthcare investment profile, with deeper healthcare specialization than generalist VCs and a stage range that overlaps with growth-stage oral health opportunities.
• Optum Ventures: Optum Ventures is the corporate venture capital arm of Optum/UnitedHealth Group, investing broadly in healthcare innovation including digital health, AI, and care delivery. It is a broad incumbent comparable to Revere's healthcare VC peer set, with much larger AUM and a broader healthcare mandate that overlaps with Revere's oral health investments.
• Khosla Ventures: Khosla Ventures is a large venture capital firm investing across technology and healthcare, including substantial health tech and biotech exposure. It is a broad incumbent that competes at the Seed-to-Series B stages in healthcare and digital health, with far greater AUM and a generalist thesis that occasionally overlaps with Revere's portfolio.
• ARCH Venture Partners: ARCH Venture Partners is a leading life sciences and technology venture capital firm with deep healthcare and biotech expertise across all stages. It is a broad incumbent comparable to Revere's healthcare VC profile, with larger fund sizes, a longer track record of healthcare exits, and a broader biotech/medtech mandate that overlaps with Revere's medical-device oral health investments.
• Sequoia Capital: Sequoia Capital is one of the largest and most established venture capital firms, with broad healthcare and consumer health exposure. It is a broad incumbent that competes for high-quality Seed-to-Series B healthcare and consumer health opportunities, with far greater AUM, brand recognition, and global reach than Revere.
• General Catalyst: General Catalyst is a major venture capital firm with a dedicated healthcare practice (Health Assurance) and broad technology investments. It is a broad incumbent that competes for Seed-to-Series B healthcare and digital health deals, with much larger fund sizes and a broader mandate that occasionally overlaps with Revere's oral health investment thesis.

Market position

Strengths6 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/revere-partners

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries1 record

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments14 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Revere Partners